Citius Pharmaceuticals (CTXR) Net Equity Issued and Repurchased (2011 - 2026)
Citius Pharmaceuticals (CTXR) recorded Net Equity Issued and Repurchased of $4.45 million in fiscal Q3 2026 (quarter ended Jun 30, 2026), down 57.5% from $10.47 million a year earlier.
Powered by 
Analysis
Citius Pharmaceuticals (CTXR) Net Equity Issued and Repurchased (2011 - 2026) Analysis & Trends
On a TTM basis, Citius Pharmaceuticals' Net Equity Issued and Repurchased came in at $41.06 million as of Jun 30, 2026, up 147.5% year-over-year; for FY2025 (ended Sep 30, 2025), it was $32.3 million, up 134.0% from FY2024.
- Annual Net Equity Issued and Repurchased has a five-year compound annual growth rate of 35.2% (FY2020 to FY2025).
- Across earlier fiscal years, Net Equity Issued and Repurchased came in at $13.8 million in FY2024 (unchanged), $13.8 million in FY2023 and $70.98 million in FY2021 (+891.8%).
- Quarterly Net Equity Issued and Repurchased has ranged from -$62,764 in fiscal Q2 2026 to $20.88 million in fiscal Q1 2026 over the past five years.
- Per Business Quant, the preceding three fiscal quarters came in at -$62,764 (Q2 2026), $20.88 million (Q1 2026) and $15.79 million (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | - |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | - |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 43.00 Mn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 6.00 Mn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | - |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 9.00 Mn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | - |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 47.70 Mn |
| 10 | Citius Pharmaceuticals | 14.55 Mn | 23.85 Mn | 1.00 Mn | 4.45 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 4.45 Mn |
| Mar 31, 2026 | -62,764.00 |
| Dec 31, 2025 | 20.88 Mn |
| Sep 30, 2025 | 15.79 Mn |
| Jun 30, 2025 | 10.47 Mn |
| Mar 31, 2025 | 3.47 Mn |
| Dec 31, 2024 | 2.57 Mn |
| Sep 30, 2024 | 84,733.00 |
| Sep 30, 2023 | -687.00 |
| Jun 30, 2023 | 13.77 Mn |
| Mar 31, 2021 | 70.98 Mn |
| Dec 31, 2020 | 500.00 |
| Jun 30, 2020 | 1.13 Mn |
| Mar 31, 2020 | 6.03 Mn |
| Dec 31, 2019 | 106.00 |
| Mar 31, 2019 | 7,216.00 |
| Dec 31, 2018 | 16,000.00 |
| Sep 30, 2018 | -6.12 Mn |
| Mar 31, 2018 | 1.76 Mn |
| Dec 31, 2017 | 5.48 Mn |
API Access
Citius Pharmaceuticals Net Equity Issued and Repurchased API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=CTXR&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "net-equity-issued-and-repurchased", "ticker": "CTXR", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=CTXR&period=max&api_key=YOUR_API_KEY");
const data = await res.json();